HMGB3 and ovarian cancer: IHC staining for HMGB3, cleaved caspase 3, and γH2AX verified that HMGB3 knockdown promoted cell apoptosis and the DNA damage response in ovarian cancer with olaparib treatment (Fig. 7E, G).